148 related articles for article (PubMed ID: 22401982)
1. The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice.
Tran K; Risingsong R; Royce D; Williams CR; Sporn MB; Liby K
Cancer Prev Res (Phila); 2012 May; 5(5):726-34. PubMed ID: 22401982
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Liby K; Risingsong R; Royce DB; Williams CR; Yore MM; Honda T; Gribble GW; Lamph WW; Vannini N; Sogno I; Albini A; Sporn MB
Clin Cancer Res; 2008 Jul; 14(14):4556-63. PubMed ID: 18628471
[TBL] [Abstract][Full Text] [Related]
3. The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer.
Tran K; Risingsong R; Royce DB; Williams CR; Sporn MB; Pioli PA; Gediya LK; Njar VC; Liby KT
Carcinogenesis; 2013 Jan; 34(1):199-210. PubMed ID: 23042302
[TBL] [Abstract][Full Text] [Related]
4. CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.
Kim EH; Deng C; Sporn MB; Royce DB; Risingsong R; Williams CR; Liby KT
Cancer Prev Res (Phila); 2012 Jan; 5(1):89-97. PubMed ID: 21933912
[TBL] [Abstract][Full Text] [Related]
5. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.
Ling X; Konopleva M; Zeng Z; Ruvolo V; Stephens LC; Schober W; McQueen T; Dietrich M; Madden TL; Andreeff M
Cancer Res; 2007 May; 67(9):4210-8. PubMed ID: 17483332
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
7. The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.
Liby K; Royce DB; Williams CR; Risingsong R; Yore MM; Honda T; Gribble GW; Dmitrovsky E; Sporn TA; Sporn MB
Cancer Res; 2007 Mar; 67(6):2414-9. PubMed ID: 17363558
[TBL] [Abstract][Full Text] [Related]
8. CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer.
Ball MS; Bhandari R; Torres GM; Martyanov V; ElTanbouly MA; Archambault K; Whitfield ML; Liby KT; Pioli PA
Sci Rep; 2020 Apr; 10(1):6560. PubMed ID: 32300202
[TBL] [Abstract][Full Text] [Related]
9. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice.
Saha PK; Reddy VT; Konopleva M; Andreeff M; Chan L
J Biol Chem; 2010 Dec; 285(52):40581-92. PubMed ID: 20956520
[TBL] [Abstract][Full Text] [Related]
10. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.
Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB
Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868
[TBL] [Abstract][Full Text] [Related]
11. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC
Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297
[TBL] [Abstract][Full Text] [Related]
12. Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells.
Konopleva M; Zhang W; Shi YX; McQueen T; Tsao T; Abdelrahim M; Munsell MF; Johansen M; Yu D; Madden T; Safe SH; Hung MC; Andreeff M
Mol Cancer Ther; 2006 Feb; 5(2):317-28. PubMed ID: 16505105
[TBL] [Abstract][Full Text] [Related]
13. Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.
Choi SH; Kim BG; Robinson J; Fink S; Yan M; Sporn MB; Markowitz SD; Letterio JJ
J Clin Invest; 2014 Jun; 124(6):2472-82. PubMed ID: 24837432
[TBL] [Abstract][Full Text] [Related]
14. The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.
Townson JL; Macdonald IC; Liby KT; Mackenzie L; Dales DW; Hedley BD; Foster PJ; Sporn MB; Chambers AF
Clin Exp Metastasis; 2011 Mar; 28(3):309-17. PubMed ID: 21234655
[TBL] [Abstract][Full Text] [Related]
15. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
[TBL] [Abstract][Full Text] [Related]
16. The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.
Liby K; Black CC; Royce DB; Williams CR; Risingsong R; Yore MM; Liu X; Honda T; Gribble GW; Lamph WW; Sporn TA; Dmitrovsky E; Sporn MB
Mol Cancer Ther; 2008 May; 7(5):1251-7. PubMed ID: 18483313
[TBL] [Abstract][Full Text] [Related]
17. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
[TBL] [Abstract][Full Text] [Related]
18. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
[TBL] [Abstract][Full Text] [Related]
20. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.
Lee HJ; Paul S; Atalla N; Thomas PE; Lin X; Yang I; Buckley B; Lu G; Zheng X; Lou YR; Conney AH; Maehr H; Adorini L; Uskokovic M; Suh N
Cancer Prev Res (Phila); 2008 Nov; 1(6):476-84. PubMed ID: 19138995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
